At the PM Society Digital Interest Group (DIG), we set out to explore the role of AI in pharma marketing—not just by discussing it but by using AI to help write the very articles we were producing. This was far more than a writing exercise; it was an experiment in collaboration between human expertise and machine intelligence.
The PM Society Digital Interest Group are pleased to share an article that challenges how effective our industries approach is to marketing.
Artificial intelligence is reshaping the pharmaceutical industry, offering powerful solutions to improve marketing, medical affairs, and operations. This article provides actionable insights for pharmaceutical professionals, through real-life examples.
The pharmaceutical industry is beginning to realise the transformative power of artificial intelligence (AI) in enhancing customer engagement. In the first article, we explored basic AI applications, such as using generative AI for content creation and data analysis.
Artificial Intelligence (AI) is revolutionising various industries, and pharmaceutical marketing is no exception.
In this illuminating video, Dr. Asif Qasim, consultant cardiologist and CEO of MedShr, shares expert advice for pharmaceutical marketers on how to effectively engage with healthcare professionals.
Our Digital Interest Group has put together a quick video showing the simple rules for success in supporting HCP’s.
Could the magical allure of a white rabbit really ignite a renewed perspective on who our customer truly is? Seemingly this is something which worked for Alice as she traversed her own Wonderland. This article is the third in the 2024 series produced by the Pharmaceutical Marketing Society’s Digital Interest Group.
This Pharmaceutical Marketing Society article is based on a recent discussion between three members of the Digital Interest Group.
This article provided an overview of various thought-provoking articles published by the PM Society Digital Interest Group (DIG) throughout 2023.
